ADIAOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Adia Med, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.13−0.01 (-7.14%)
Close on Oct 19, 2026
- Market cap
- $20.98M
- P/E (TTM)
- –
- Dividend yield
- –
Adia Med, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Adia Med [Member] | $329.82K | $104.85K | – | $26.00K | $70.70K | – | 68.0% | +1168.5% |
| Adia Labs [Member] | $155.57K | $71.43K | – | $88.79K | $0 | – | 32.0% | +75.2% |
| Corporate Segment [Member] | $0 | $0 | – | $2.27K | $0 | – | 0.0% | -100.0% |
| Biolete [Member] | $0 | $0 | – | $1.09K | $1.06K | – | 0.0% | -100.0% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | YoY |
|---|---|---|---|---|---|---|---|
| Adia Med [Member] | $128.96K | -$43.29K | – | -$45.37K | -$24.35K | – | -384.2% |
| Adia Labs [Member] | $14.86K | $31.83K | – | – | – | – | – |
| Biolete [Member] | $0 | $0 | – | $686 | $371 | – | -100.0% |
| Corporate Segment [Member] | -$91.99K | -$140.45K | – | -$81.88K | -$86.57K | – | +12.4% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Medical Procedures [Member] | $329.82K | $104.85K | – | $26.00K | $70.70K | – | 68.0% | +1168.5% |
| Sales Of Biologics [Member] | $151.75K | $69.78K | – | $87.50K | $0 | – | 31.3% | +73.4% |
| Shipping And Delivery [Member] | $3.82K | $1.65K | – | $1.29K | $0 | – | 0.8% | +196.2% |
| Sales Of Supplements [Member] | $0 | $0 | – | $1.09K | $1.06K | – | 0.0% | -100.0% |
| Services [Member] | $0 | – | – | $2.27K | – | – | 0.0% | -100.0% |
| Sales Of Prducts And Services [Member] | – | $69.78K | – | – | $0 | – | – | – |
By region
From the segment and revenue-disaggregation notes of Adia Med's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.